Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Silver will perform like gold on steroids

This past March, I asked a highly successful investment advisor what he thought about gold. Since he deals almost exclusively with very high net-worth individuals, his point of view was especially intriguing. He confided to me that many of his clients had been asking for g...
Peter Krauth | December 10, 2012 |

April 21st 2020, Crypto Chartbook: Uncertainty – opportunity in disguise

Uncertainty – opportunity in disguise We have just entered into a future with a higher degree of uncertainty. Times of more rapid change promise innovation, a higher degree of risk taking, in short evolution on steroids awaits. History shows that times like these spell op...
Korbinian Koller | April 22, 2020 |

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'

The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report. In an Aug. 8 research note, analyst Joseph Pantginis reviewed Capricor Therapeutics Inc.'s (CAPR:NASDAQ) Q2/19 financials and reported t...
Streetwise Reports | August 14, 2019 |

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. Yesterday afternoon, Vi...
Streetwise Reports | December 7, 2019 |

'Stay Tuned for Data' from Regenerative Medicine Firm with 'Blockbuster Opportunity'

The compelling aspects of this life sciences story are presented in a Dawson James report. In a Jan. 28 research note, analyst Jason Kolbert reported that Dawson James Securities increased its target price on Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX) to $15 pe...
Streetwise Reports | February 3, 2020 |

The Post-reversal Rallies and Upside Targets for GDX, GDXJ

Yesterday, we told our subscribers that probably all markets (or most thereof) are about to correct. And it seems that’s exactly what is happening. Crude oil is moving higher . The USD Index declined from 103.82 to about 102.72 (at the moment of writing these ...
Przemyslaw Radomski, CFA | March 20, 2020 |

The Coming Great Global Reset

In the first quarter of 2019, global debt hit $246.5 trillion. Encouraged by lower interest rates, governments went on a borrowing binge as they ramped up spending, adding $3 trillion to world debt in Q1 alone. It reverses a trend that started in the beginning of 2018, of ...
Richard (Rick) Mills | October 21, 2019 |

Q4 Guesstimates: Precious Metals, Miners and Stocks

You have all heard me opine about the (un)dependability of rules-based investing in a managed market environment, where it is not kosher for a financial advisor to fire off a promotional tweet about their favorite stock but it is perfectly acceptable for a sitting presi...
Streetwise Reports | October 23, 2019 |

Trump or Sanders? Both will pile up the debt

Whether it’s a Democrat or a Republican installed in the White House this November, you can count on fiscal discipline going out the window. Neither the incumbent, President Donald J. Trump, nor the leading Democratic contender to replace him, Bernie Sanders,...
Richard (Rick) Mills | February 26, 2020 |

David Smith: 'Common Sense 2.0' Is a Call to Action to Hold Government Accountable

Maurice Jackson: Today, we're going to discuss a very, very important topic and that is debt slavery. We're also going to discuss common sense, and more importantly, what actions you need to take to protect your family. Joining us for a conversation is David Smith from m...
Streetwise Reports | June 17, 2020 |